3 results on '"Balanag, V. M."'
Search Results
2. Reminder systems and late patient tracers in the diagnosis and management of tuberculosis
- Author
-
Liu, Q., Abba, Katharine, Alejandria, M. M., Balanag, V. M., Berba, R. P., and Lansang, M. A. D.
- Subjects
education ,wf_220 ,wf_200 ,wf_310 - Abstract
Background\ud Reminder systems and late patient tracers as strategies to improve patients' adherence to tuberculosis screening, diagnosis, and treatment are used in some countries, but their effectiveness has not previously been systematically reviewed.\ud Objectives\ud To assess the effects of reminder systems and late patient tracers on completion of diagnostics, commencement of treatment in people referred for curative or prophylactic treatment of tuberculosis, completion of treatment in people starting curative or prophylactic treatment for tuberculosis, and cure in people being treated for active tuberculosis.\ud Search strategy\ud We searched the Cochrane Infectious Diseases Group Specialized Register ( June 2008), Cochrane Effective Practice and Organization of Care Group Specialized Register ( April 2007), CENTRAL ( The Cochrane Library 2008, Issue 2), MEDLINE ( 1966 to June 2008), EMBASE ( 1974 to June 2008), LILACS ( 1982 to June 2008), CINAHL ( 1982 to June 2008), SCI-EXPANDED ( 1945 to June 2008), SSCI ( 1956 to June 2008), mRCT ( June 2008), Indian Journal of Tuberculosis ( 1983 to June 2008), and reference lists. We also contacted researchers working in the field.\ud Selection criteria\ud Randomized controlled trials (RCTs), including cluster RCTs and quasi-RCTs, and controlled before-and-after studies comparing any reminders or late patient tracers with no or other kinds of reminders or late patient tracers. We included people in any setting who require treatment for tuberculosis or require prophylaxis against tuberculosis and are referred to tuberculosis diagnostic or screening services.\ud Data collection and analysis\ud Two authors independently assessed trial risk of bias and extracted data. Nometa-analysis could be undertaken due to the heterogeneity of interventions across trials.\ud Main results\ud Nine trials involving 5257 participants met the inclusion criteria. Three assessed the use of late patient tracers, and six assessed reminder systems. Late patient tracers ( home visit and letter) were shown to be beneficial in increasing adherence to tuberculosis treatment compared with no late patient tracer. The results from almost all the reminder trials, except one, show benefits of different types of reminders compared to no reminder on adherence to tuberculosis clinic appointments.\ud Authors' conclusions\ud The included trials show significantly better outcomes among those tuberculosis patients for which late patient tracers and reminders are used. Studies of good quality ( large and with rigorous study design) are needed to decide the most effective late patient tracer actions and reminders in different settings. Future studies of reminders in chemoprophylaxis and treatment settings would be useful.
- Published
- 2008
3. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma.
- Author
-
Balanag VM, Yunus F, Yang PC, and Jorup C
- Subjects
- Acute Disease, Administration, Inhalation, Adolescent, Adrenal Cortex Hormones administration & dosage, Adrenal Cortex Hormones adverse effects, Adrenergic beta-Agonists adverse effects, Adult, Aged, Aged, 80 and over, Albuterol adverse effects, Budesonide administration & dosage, Budesonide adverse effects, Dose-Response Relationship, Drug, Double-Blind Method, Drug Combinations, Electrocardiography, Ethanolamines administration & dosage, Ethanolamines adverse effects, Female, Formoterol Fumarate, Humans, Male, Middle Aged, Respiratory Function Tests, Adrenal Cortex Hormones therapeutic use, Adrenergic beta-Agonists administration & dosage, Adrenergic beta-Agonists therapeutic use, Albuterol therapeutic use, Asthma drug therapy, Budesonide therapeutic use, Ethanolamines therapeutic use
- Abstract
This study compared the efficacy and safety of budesonide/formoterol (Symbicort) Turbuhaler)) with salbutamol pressurized metered-dose inhaler (pMDI) with spacer for relief of acute bronchoconstriction in patients with asthma. In this randomized, double-blind, parallel-group study, patients (n = 104 allocated to treatment; n = 103 received treatment; mean age 45 years) seeking medical attention for acute asthma (mean FEV(1) 43% of predicted) received two doses repeated at t = -5 and 0 min of either budesonide/formoterol (320/9 microg, two inhalations) or salbutamol (100 microg x eight inhalations); total doses 1280/36 microg and 1600 microg, respectively. All patients received prednisolone 60 mg at 90 min and FEV(1) was assessed over 3h. FEV(1) 90 min after dosing (primary variable) increased compared with pre-dose FEV(1) by an average of 30% and 32% for budesonide/formoterol and salbutamol, respectively (P = 0.66), with similar increases at all timepoints from 3 to 180 min for both groups. Mean pulse rate over 3h was significantly higher in the salbutamol group versus the budesonide/formoterol group (92 vs. 88 bpm; P < 0.01). No treatment differences were seen for other vital signs, including ECG. High-dose budesonide/formoterol was effective and well tolerated for the treatment of acute asthma, with rapid onset of efficacy and a safety profile over 3h similar to high-dose salbutamol.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.